Colorectal cancer screening: a global overview of existing programmes

EH Schreuders, A Ruco, L Rabeneck, RE Schoen… - Gut, 2015 - gut.bmj.com
Colorectal cancer (CRC) ranks third among the most commonly diagnosed cancers
worldwide, with wide geographical variation in incidence and mortality across the world …

[HTML][HTML] Advances in fecal occult blood tests: the FIT revolution

GP Young, EL Symonds, JE Allison, SR Cole… - Digestive diseases and …, 2015 - Springer
There is a wide choice of fecal occult blood tests (FOBTs) for colorectal cancer screening.
Goal: To highlight the issues applicable when choosing a FOBT, in particular which FOBT is …

[HTML][HTML] Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test …

JE Allison, CG Fraser, SP Halloran, GP Young - Gut and liver, 2014 - ncbi.nlm.nih.gov
Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which
colorectal cancer (CRC) is screened. Although these tests are being performed worldwide …

Reduced accumulation of specific microRNAs in colorectal neoplasia

MZ Michael, SM O'Connor… - Molecular cancer …, 2003 - AACR
Short non-coding RNAs are known to regulate cellular processes including development,
heterochromatin formation, and genomic stability in eukaryotes. Given the impact of these …

Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy …

V Medina, B Edmonds, GP Young, R James… - Cancer research, 1997 - AACR
The induction of apoptosis of tumor cells by the colonic fermentation product butyrate is
thought to be an important mechanism in protection against colorectal cancer. Because a …

[HTML][HTML] Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study

AK Win, JP Young, NM Lindor, KM Tucker… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Colorectal and Other Cancer Risks for Carriers and Noncarriers From Families With a DNA
Mismatch Repair Gene Mutation: A Prospective Cohort Study - PMC Back to Top Skip to main …

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery

S Parry, AK Win, B Parry, FA Macrae, LC Gurrin… - Gut, 2011 - gut.bmj.com
Background Surgical management of colon cancer for patients with Lynch syndrome who
carry a mismatch repair (MMR) gene mutation is controversial. The decision to remove more …

Effect of resistant starch on fecal bulk and fermentation-dependent events in humans

J Phillips, JG Muir, A Birkett, ZX Lu, GP Jones… - The American journal of …, 1995 - Elsevier
This study investigated the effect of two diets, which differed in resistant starch (RS)
concentration, on fecal bulk and fermentation-dependent events in 11 humans. Amounts of …

Cancer Risks for MLH1 and MSH2 Mutation Carriers

JG Dowty, AK Win, DD Buchanan, NM Lindor… - Human …, 2013 - Wiley Online Library
ABSTRACT We studied 17,576 members of 166 MLH 1 and 224 MSH 2 mutation‐carrying
families from the C olon C ancer F amily R egistry. Average cumulative risks of colorectal …

[HTML][HTML] Amylase-resistant starch plus oral rehydration solution for cholera

BS Ramakrishna, S Venkataraman… - … England Journal of …, 2000 - Mass Medical Soc
Background Although standard glucose-based oral rehydration therapy corrects the
dehydration caused by cholera, it does not reduce the diarrhea. Short-chain fatty acids …